Works matching IS 14611457 AND DT 2013 AND VI 16 AND IP 4

Results: 21

Effects of pregabalin on sleep in generalized anxiety disorder.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 925, doi. 10.1017/S1461145712000922

By:

Holsboer-Trachsler, Edith;
Prieto, Rita

Publication type:

Article

Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 919, doi. 10.1017/S1461145712001174

By:

Kiselycznyk, Carly;
Xiaoqun Zhang;
Huganir, Richard L.;
Holmes, Andrew;
Svenningsson, Per

Publication type:

Article

Region-specific effects on BDNF expression after contingent or non-contingent cocaine i.v. self-administration in rats.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 913, doi. 10.1017/S146114571200096X

By:

Fumagalli, Fabio;
Moro, Federico;
Caffino, Lucia;
Orrù, Alessandro;
Cassina, Chiara;
Giannotti, Giuseppe;
Clemente, Angelo Di;
Racagni, Giorgio;
Riva, Marco A.;
Cervo, Luigi

Publication type:

Article

Loss of asymmetric spine synapses in prefrontal cortex of motor-asymptomatic, dopamine-depleted, cognitively impaired MPTP-treated monkeys.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 905, doi. 10.1017/S1461145712000892

By:

Elsworth, John D.;
Leranth, Csaba;
Redmond Jr, D. Eugene;
Roth, Robert H.

Publication type:

Article

Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 889, doi. 10.1017/S1461145712000739

By:

Brown, Jordan W.;
Basso, Ana M.;
Rueter, Lynne E.;
Min Zhang

Publication type:

Article

Monoamine oxidase A and A/B knockout mice display autistic-like features.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 869, doi. 10.1017/S1461145712000715

By:

Bortolato, Marco;
Godar, Sean C.;
Alzghoul, Loai;
Junlin Zhang;
Darling, Ryan D.;
Simpson, Kimberly L.;
Bini, Valentina;
Kevin Chen;
Wellman, Cara L.;
Lin, Rick C. S.;
Shih, Jean C.

Publication type:

Article

Selective deletion of leptin receptors in adult hippocampus induces depression-related behaviours.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 857, doi. 10.1017/S1461145712000703

By:

Ming Guo;
Huang, Tung-Yi;
Garza, Jacob C.;
Chua, Streamson C.;
Lu, Xin-Yun

Publication type:

Article

The opioid placebo analgesia is mediated exclusively through μ-opioid receptor in rat.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 849, doi. 10.1017/S1461145712000673

By:

Zhang, Rui-Rui;
Zhang, Wen-Cai;
Wang, Jin-Yan;
Guo, Jian-You

Publication type:

Article

Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 835, doi. 10.1017/S146114571200065X

By:

Ying Xu;
Jianchun Pan;
Ling Chen;
Chong Zhang;
Jiao Sun;
Jianxin Li;
Nguyen, Linda;
Nair, Neetu;
Hanting Zhang;
O'Donnell, James M.

Publication type:

Article

Inhibition of the PI3 kinase cascade in corticolimbic circuit: temporal and differential effects on contextual fear and extinction.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 825, doi. 10.1017/S1461145712000636

By:

Kritman, Milly;
Maroun, Mouna

Publication type:

Article

Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 813, doi. 10.1017/S1461145712000612

By:

Tamburella, Alessandra;
Leggio, Gian Marco;
Micale, Vincenzo;
Navarria, Andrea;
Bucolo, Claudio;
Cicirata, Valentina;
Drago, Filippo;
Salomone, Salvatore

Publication type:

Article

Involvement of CaMKIV in neurogenic effect with chronic fluoxetine treatment.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 803, doi. 10.1017/S1461145712000570

By:

Ning Song;
Nakagawa, Shin;
Izumi, Takeshi;
Toda, Hiroyuki;
Kato, Akiko;
Boku, Shuken;
Inoue, Takeshi;
Sakagami, Hiroyuki;
Li, Xiaobai;
Koyama, Tsukasa

Publication type:

Article

Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 791, doi. 10.1017/S1461145712000582

By:

Mueller, Melanie;
Yuan, Jie;
McCann, Una D.;
Hatzidimitriou, George;
Ricaurte, George A.

Publication type:

Article

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 783, doi. 10.1017/S1461145712000880

By:

Ghaleiha, Ali;
Asadabadi, Mahtab;
Mohammadi, Mohammad-Reza;
Shahei, Maryam;
Tabrizi, Mina;
Hajiaghaee, Reza;
Hassanzadeh, Elmira;
Akhondzadeh, Shahin

Publication type:

Article

Analysis of 34 candidate genes in bupropion and placebo remission.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 771, doi. 10.1017/S1461145712000843

By:

Tiwari, Arun K.;
Zai, Clement C.;
Sajeev, Gautam;
Arenovich, Tamara;
Miiller, Daniel J.;
Kennedy, James L.

Publication type:

Article

Effects of amphetamine on the human brain opioid system - a positron emission tomography study.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 763, doi. 10.1017/S1461145712000818

By:

Guterstam, Joar;
Jayaram-Lindström, Nitya;
Cervenka, Simon;
Frost, J. James;
Farde, Lars;
Halldin, Christer;
Franck, Johan

Publication type:

Article

Speed of response in ultrabrief and brief pulse width right unilateral ECT.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 755, doi. 10.1017/S1461145712000806

By:

Loo, Colleen K.;
Garfield, Joshua B. B.;
Katalinic, Natalie;
Schweitze, Isaac;
Hadzi-Pavlovic, Dusan

Publication type:

Article

Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 745, doi. 10.1017/S1461145712000764

By:

Vernaleken, Ingo;
Klomp, Majken;
Moeller, Olaf;
Raptis, Mardjan;
Nagels, Arne;
Rösch, Frank;
Schaefer, Wolfgang M.;
Cumming, Paul;
Gründer, Gerhard

Publication type:

Article

Gender-specific abnormalities in the serotonin transporter system in panic disorder.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 733, doi. 10.1017/S1461145712000776

By:

Cannon, Dara M.;
Klaver, Jacqueline M.;
Klug, Summer A.;
Carlson, Paul J.;
Luckenbaugh, David A.;
Ichise, Masanori;
Drevets, Wayne C.

Publication type:

Article

The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 721, doi. 10.1017/S1461145712000752

By:

Nathan, Pradeep J.;
Watson, Jeannette;
Lund, Jesper;
Davies, Ceri H.;
Peters, Gary;
Dodds, Chris M.;
Swirski, Bridget;
Lawrence, Philip;
Bentley, Graham D.;
O'Neill, Barry V.;
Robertson, Jon;
Watson, Stephen;
Jones, Gareth A.;
Maruff, Paul;
Croft, Rodney J.;
Laruelle, Marc;
Bullmore, Edward T.

Publication type:

Article

Muscarinic M1 receptor agonists: can they improve cognitive performance?

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 717, doi. 10.1017/S1461145712001113

By:

Scarr, Elizabeth

Publication type:

Article

Works matching IS 14611457 AND DT 2013 AND VI 16 AND IP 4

Effects of pregabalin on sleep in generalized anxiety disorder.

Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice.

Region-specific effects on BDNF expression after contingent or non-contingent cocaine i.v. self-administration in rats.

Loss of asymmetric spine synapses in prefrontal cortex of motor-asymptomatic, dopamine-depleted, cognitively impaired MPTP-treated monkeys.

Preclinical evaluation of non-imidazole histamine H<sub>3</sub> receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

Monoamine oxidase A and A/B knockout mice display autistic-like features.

Selective deletion of leptin receptors in adult hippocampus induces depression-related behaviours.

The opioid placebo analgesia is mediated exclusively through μ-opioid receptor in rat.

Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.

Inhibition of the PI3 kinase cascade in corticolimbic circuit: temporal and differential effects on contextual fear and extinction.

Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant.

Involvement of CaMKIV in neurogenic effect with chronic fluoxetine treatment.

Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Analysis of 34 candidate genes in bupropion and placebo remission.

Effects of amphetamine on the human brain opioid system - a positron emission tomography study.

Speed of response in ultrabrief and brief pulse width right unilateral ECT.

Vulnerability to psychotogenic effects of ketamine is associated with elevated D<sub>2/3</sub>-receptor availability.

Gender-specific abnormalities in the serotonin transporter system in panic disorder.

The potent M<sub>1</sub> receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.

Muscarinic M<sub>1</sub> receptor agonists: can they improve cognitive performance?